Hotline:+86 2884841969
Outbound Sales&Marketing
 
Cynthia 
Tel: +86 2884841969 
Mobile: +86 17390183901 (English) 
Skype/Wechat:+86 18716376478
 
Mr. Yang  
Tel: +86 2884871826
Mobile: +86 13908183771   
Email: yangcx@enlaibio.com
 
Amy Yang
Tel:+86-28-84841969
Mobile:+8618980839296
QQ:551604319
Skype/Wechat:+86 18280195889
Email:551604319@qq.com
Industry News Your current location:Homepage >Industry News
请添加图片
First line treatment for chronic lymphocytic leukemia

As a first line treatment drugs for chronic lymphocytic leukemia, Ibrutinib improves survival compared with Ofatumumab in patients with previously treated Chronic Lymphocytic Leukemia.

From Poverty to Harvard Postdoc2013-10-24

Fingerprints Expose Chemical Identities 2019-01-04

2019 CPHI Shanghai Bio-Pharm Expo 2019-08-18